UBS AM’s Pactiv Evergreen PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-105,861
Closed -$1.91M – 2745
2025
Q1
$1.91M Buy
105,861
+706
+0.7% +$12.6K ﹤0.01% 2013
2024
Q4
$1.84M Buy
105,155
+26,705
+34% +$361K ﹤0.01% 2093
2024
Q3
$903K Sell
78,450
-21,078
-21% -$242K ﹤0.01% 2447
2024
Q2
$1.13M Buy
99,528
+44,797
+82% +$596K ﹤0.01% 2314
2024
Q1
$784K Buy
54,731
+20,059
+58% +$284K ﹤0.01% 2128
2023
Q4
$475K Hold
34,672
– – ﹤0.01% 2335
2023
Q3
$282K Hold
34,672
– – ﹤0.01% 2450
2023
Q2
$277K Hold
34,672
– – ﹤0.01% 2495
2023
Q1
$277K Sell
34,672
-21,956
-39% -$226K ﹤0.01% 2495
2022
Q4
$643K Buy
56,628
+19,902
+54% +$217K ﹤0.01% 2069
2022
Q3
$321K Buy
+36,726
New +$381K ﹤0.01% 2479

UBS AM's PTVE Position: Q2 2025 in Review

UBS AM sold out of Pactiv Evergreen (PTVE) in Q2 2025, closing a stake of 105,861 shares — an estimated $1.91M sold.

UBS AM first reported a position in PTVE in Q3 2022 and held it in 11 quarters. The position peaked at $1.91M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • UBS AM reported no remaining Pactiv Evergreen position as of Q2 2025 after selling out during the quarter.
  • UBS AM sold 105,861 Pactiv Evergreen shares in Q2 2025, an estimated $1.91M.
  • UBS AM first reported a position in Pactiv Evergreen in Q3 2022 and held it in 11 quarters.
  • UBS AM's Pactiv Evergreen position peaked at $1.91M in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen as of Q2 2025.

Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.